Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma

L Vincent; P Ceballos; C Plassot; J C Méniane; P Quittet; R Navarro; C Cyteval; V Szablewski; Z Y Lu; T Kanouni; J Moreaux; G Cartron; B Klein; N Fegueux

doi:10.1038/bcj.2015.48

Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma

Blood Cancer J. 2015 Aug 21;5(8):e341. doi: 10.1038/bcj.2015.48.

Authors

L Vincent^{1

2

3}, P Ceballos¹, C Plassot^{2

3}, J C Méniane¹, P Quittet¹, R Navarro¹, C Cyteval⁴, V Szablewski⁵, Z Y Lu⁶, T Kanouni¹, J Moreaux^{7

8}, G Cartron^{1

2

3}, B Klein^{2

3

7

8}, N Fegueux¹

Affiliations

¹ Département d'Hématologie Clinique, CHRU de Montpellier, Montpellier, France.
² Université MONTPELLIER 1, UFR de Médecine, Montpellier, France.
³ Laboratoire de Biostatistiques, IURC, Montpellier, France.
⁴ Département d'Imagerie Médicale CHRU de Montpellier, Montpellier, France.
⁵ Département d'Anatomopathologie, CHRU de Montpellier, Montpellier, France.
⁶ Unité de Thérapie Cellulaire, CHRU de Montpellier, Montpellier, France.
⁷ INSERM, U1040, Montpellier, France.
⁸ Laboratory for Innovative Biology, Department of Biological Hematology, CHRU de Montpellier, Montpellier, France.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation*
Humans
Male
Middle Aged
Multiple Myeloma / mortality
Multiple Myeloma / pathology*
Multiple Myeloma / therapy
Neoplasm Recurrence, Local
Transplantation Conditioning
Transplantation, Homologous
Treatment Outcome